Akarna Therapeutics
Latest round
- Series B
Last raised
- Jan 2016
Total raised
- $16M
Investors
- 3
About Akarna Therapeutics
Founded in 2014 and based in Cambridge, UK, Akarna Therapeutics Ltd. is a biopharmaceutical company that develops novel small molecule therapeutics that target inflammatory and fibrotic diseases.
Who invested in Akarna Therapeutics
3 investors across 2 rounds
See all investors in Akarna Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Akarna Therapeutics
Who invested in Akarna Therapeutics?
Akarna Therapeutics has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Akarna Therapeutics raised?
Akarna Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Akarna Therapeutics last raise money?
Akarna Therapeutics's most recent round on record is a Series B, in Jan 2016.
What does Akarna Therapeutics do?
Founded in 2014 and based in Cambridge, UK, Akarna Therapeutics Ltd.
Where is Akarna Therapeutics headquartered?
Akarna Therapeutics is headquartered in Cambridge, UK.
Which VCs invest in companies like Akarna Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back pharmaceuticals companies at Akarna Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Akarna Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.